Koss Corp (NASDAQ:KOSS) Big Money Sentiment Index Increased in Q3 2018 to 2.67

Koss Corporation (NASDAQ:KOSS) Corporate Logo

“Big money” Positions

In 2018 Q3 Koss Corp (NASDAQ:KOSS) big money sentiment increased to 2.67, SEC.gov filings reveal. So its up 2.24, from 2018Q2’s 0.43. 8 investment managers started new and increased holdings, while 3 sold and reduced their equity positions in Koss Corp so the sentiment is more positive. Funds own 786,840 shares, up from 671,454 shares in 2018Q2. Funds holding Koss Corp in top 10 was flat from 0 to 0 for the same number . 1 Investors Sold All; 2 Reduced Holdings; 4 increased holdings while 4 investment managers bought holdings.

Biggest Koss Corp Investors

As of 2018 Q3 Minerva Advisors Llc has 0.33% invested in Koss Corp. As of 2018 Q3, 44,592 shares of Koss Corp are owned by Thompson Davis & Co. Inc.. Cibc Bank Usa reported 79,661 shares. Acadian Asset Management Llc revealed 6,476 shares position in Koss Corp. The North Carolina-based fund Bank Of America Corp De looks positive on Koss Corp, possessing 19,559 shares.

Koss Corporation, together with its subsidiaries, designs, makes, and sells stereo headphones and related accessories in the United States, PeopleÂ’s Republic of China, Czech Republic, Sweden, Malaysia, Canada, Russia, and internationally.The firm is valued at $13.89 million. It offers high-fidelity headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise canceling headphones.Currently it has negative earnings. The firm sells its products through national retailers, distributors, audio specialty stores, the Internet, direct mail catalogs, regional department store chains, discount department stores, grocery stores, electronics retailers, military exchanges, and prisons under the Koss name, as well as private label.

The stock decreased 0.23% or $0.0043 during the last trading session, reaching $1.8757.Koss Corporation has volume of 2,305 shares. Since March 4, 2018 KOSS has risen 18.29% and is uptrending. KOSS outperformed by 18.29% the S&P 500.

Minerva Ltd Co reported 229,869 shs. Cibc Commercial Bank Usa, a Illinois-based fund reported 79,661 shs. Acadian Asset Management Ltd holds 0% or 6,476 shs in its capital. Northern Tru holds 15,841 shs or 0% of its capital. Dimensional Fund Lp holds 0% or 163,051 shs. Vanguard Gru Inc Inc has invested 0% in Koss Corporation (NASDAQ:KOSS). Blackrock reported 8,843 shs. Retail Bank Of Ny Mellon Corp invested 0% of its capital in Koss Corporation (NASDAQ:KOSS). Citadel Advsr Lc holds 0% or 10,259 shs in its capital. Morgan Stanley owns 20,088 shs or 0% of their US capital. National Bank Of America De has invested 0% in Koss Corporation (NASDAQ:KOSS). Deutsche Bancshares Ag holds 51,800 shs. Renaissance Technologies Lc holds 0% or 64,096 shs in its capital. Susquehanna International Grp Limited Liability Partnership holds 0% of its capital in Koss Corporation (NASDAQ:KOSS) for 21,334 shs. Thompson Davis, a Virginia-based fund reported 44,592 shs.

For more Koss Corporation (NASDAQ:KOSS) news released recently go to: Globenewswire.com, Globenewswire.com, Globenewswire.com, Globenewswire.com or Nasdaq.com. The titles are as follows: “Koss Corp. Releases Third Quarter Results Nasdaq:KOSS – GlobeNewswire” released on May 10, 2018, “New England Journal of Medicine publishes positive detailed results from Praluent® (alirocumab) cardiovascular outcomes trial – GlobeNewswire” on November 07, 2018, “FDA to review supplemental Biologics License Application for Praluent® (alirocumab) Injection as potential treatment to reduce major adverse cardiovascular events – GlobeNewswire” with a publish date: September 12, 2018, “Sanofi: FDA to Conduct Priority Review of Cemiplimab as a Potential Treatment for Advanced Cutaneous Squamous Cell Carcinoma – GlobeNewswire” and the last “Sanofi: Positive results presented from two Phase 3 trials of Dupixent® (dupilumab) in severe chronic rhinosinusitis with nasal polyps – Nasdaq” with publication date: February 25, 2019.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.